Tonix Pharmaceuticals Holding (TNXP) EPS (Basic) (2019 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly EPS (Basic) of -$2.93 for Q1 2026, down 3.28% year-over-year from -$3.03 in Q1 2025, and up 46.8% quarter-over-quarter from -$5.51 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) EPS (Basic) (2019 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's EPS (Basic) history runs 8 years deep, the most recent figure standing at -$2.93 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 3.28% year-over-year to -$2.93; the TTM figure through Mar 2026 stood at -$10.75 (up 51.69% YoY), while the FY2025 annual figure was -$14.57, up 91.75% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$2.93, up from -$5.51 in the prior quarter.
- The five-year high for EPS (Basic) was -$2.84 in Q1 2025, with the low at -$32565.0 in Q1 2022.
- The 5-year median for EPS (Basic) is -$1928.4 (2024), against an average of -$7204.2.
- The sharpest annual moves came in 2025 and 2026: EPS (Basic) surged 99.8% in 2025, then retreated 3.28% in 2026.
- Tonix Pharmaceuticals Holding's EPS (Basic) stood at -$19073.3 in 2022, then surged by 73.1% to -$5130.9 in 2023, then soared by 99.41% to -$30.02 in 2024, then jumped by 81.64% to -$5.51 in 2025, then soared by 46.8% to -$2.93 in 2026.
- Business Quant data shows TNXP's EPS (Basic) at -$2.93 in Q1 2026, -$5.51 in Q4 2025, and -$3.59 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -2.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.44 |
| Mar 31, 2026 | -2.93 |
| Dec 31, 2025 | -5.51 |
| Sep 30, 2025 | -3.59 |
| Jun 30, 2025 | -3.86 |
| Mar 31, 2025 | -2.84 |
| Dec 31, 2024 | -30.02 |
| Sep 30, 2024 | -22.88 |
| Jun 30, 2024 | -1,928.37 |
| Mar 31, 2024 | -591.06 |
| Dec 31, 2023 | -5,130.89 |
| Sep 30, 2023 | -5,840.29 |
| Jun 30, 2023 | -8,571.95 |
| Mar 31, 2023 | -10,418.24 |
| Dec 31, 2022 | -19,073.31 |
| Sep 30, 2022 | -13,820.22 |
| Jun 30, 2022 | -24,459.82 |
| Mar 31, 2022 | -32,564.95 |
| Dec 31, 2021 | -52,492.01 |
| Sep 30, 2021 | -32,335.08 |